SANTA ANA, CA--(Marketwired - Aug 16, 2016) - BioLargo, Inc. (
BioLargo Water researchers also revealed the results of hundreds of studies showcasing the AOS Filter's water purification capabilities. This robust technology eliminates water-borne bacteria more effectively and at a lower cost than competing advanced water treatment technologies, and can boast a safe and environmentally friendly build and operation. The research team was lauded for its work on water disinfection and decontamination that clearly placed the AOS Filter far and above competing technologies and has paved the way for development of the commercial AOS Filter. Finally, the team presented plans to test and develop the Alpha Prototype AOS Filter into a pre-commercial pilot model (the Beta prototype), which is the last step before commercialization of this powerful water treatment solution.
The company's Chief Science Officer, Kenneth R. Code, added, "I am particularly pleased with the expert data collection, and our presentations to potential strategic partners also help affirm scalability of the AOS technology to industrial and municipal scale."
Dennis P Calvert, the President & CEO of BioLargo, commented, "We are marching forward to impact the world for good. Science confirms our scalable AOS Filter system is more effective at disinfection than any known competing technologies at less than < 1/20th the energy (cost). Now that the Alpha unit is complete, we are able to more fully demonstrate its scalability to meet heavy industrial and municipal client needs. We are thankful for the substantial support from the Canadian federal and provincial systems as well as industry members that continue to directly support our important work. We are also thankful for our shareholders that consistently support our mission to ' Make Life Better' and deliver value to our stakeholders. The best of times for BioLargo is ahead."
About BioLargo, Inc.
BioLargo, Inc. ( BLGO ) makes life better by delivering sustainable technology-based products that help solve some of the most widespread problems threatening the world's supply of water, food, agriculture, healthcare and energy. More information can be found about the company and its subsidiaries at www.BioLargo.com . Its subsidiary BioLargo Water, Inc. ( www.BioLargoWater.com ) showcases the Advanced Oxidation Systems, including its AOS Filter -- a product in development specifically designed to eliminate common, troublesome, and dangerous (toxic) contaminants in water in a fraction of the time and cost of current technologies. It is the winner of the Technology Star award by New Technology Magazine for its breakthrough innovation for the oil industry and is named the Technology Innovation Leader in the water treatment market by Frost & Sullivan. BioLargo also owns a 50% interest in the Isan System, which was honored with a "Top 50 Water Company for the 21st Century" award by the Artemis Project now being commercialized under a license to Clarion Water, Inc. BioLargo's subsidiary Odor-No-More Inc., features award-winning products serving the pet, equine, military supply and consumer markets, including the Nature's Best Solution® and Deodorall® brands ( www.OdorNoMore.com ). BioLargo's subsidiary Clyra Medical Technologies, Inc. ( www.ClyraMedical.com ) focuses on advanced wound care management.
Safe Harbor Statement
The statements contained herein, which are not historical, are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements, including, but not limited to, the risks and uncertainties included in BioLargo's current and future filings with the Securities and Exchange Commission, including those set forth in BioLargo's Annual Report on Form 10-K.
Company Contact Dennis Calvert President and CEO BioLargo, Inc. 949-643-9540 x1
